May 18, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) will build a $200 million, high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600 jobs by 2030.
BD plans to begin construction of the new plant in late 2021. The new facility will be the fourth manufacturing plant for BD in Spain.
The site will initially have a workforce of 150 people and encompass an area of 86,000 square feet.
By 2030 it is expected to employ up to 600 people with an area of 323,000 square feet. The new facility will meet high sustainability and eco-efficiency standards, and it will be a fully digital site, incorporating the latest in intelligent and autonomous technologies, also knowns as Industry 4.0 solutions.
The new site represents a portion of the $1.2 billion investment over four years that was announced in December 2020 to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) as part of BD’s 2025 growth strategy.
The new site also continues BD’s commitment to Spain, where currently has three production plants that collectively produce a total of 10 billion medical devices each year and employ 1,500 people. The Fraga plant is a key production site for the manufacture of COVID-19 vaccination injection devices.
“BD’s new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical companies that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs,” said Eric Borin, worldwide president of BD Pharmaceutical Systems. “This new plant will also add needed capacity to support major vaccination campaigns, such as the one currently taking place in response to the COVID-19 pandemic.”